相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Nivolumab plus Ipilimumab versus Existing Immunotherapies in Patients with PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis
Koichi Ando et al.
CANCERS (2020)
Anti-Angiogenic Properties of Ginsenoside Rg3
Maryam Nakhjavani et al.
MOLECULES (2020)
Lung Cancer
Faria Nasim et al.
MEDICAL CLINICS OF NORTH AMERICA (2019)
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
Yuening Xiang et al.
CANCER MEDICINE (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer
K. M. Islam et al.
BMC CANCER (2019)
Chinese Medicine in Cancer Treatment - How is it Practised in the East and the West?
T-H So et al.
CLINICAL ONCOLOGY (2019)
Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
Hua Luo et al.
CHINESE MEDICINE (2019)
Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway
Tianhua Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Ginsenoside Rg3 promotes the antitumor activity of gefitinib in lung cancer cell lines
Yuemei Dai et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
VEGF as a potential target in lung cancer
Daniela Frezzetti et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Anticancer effects of ginsenoside Rg3 (Review)
Mengyao Sun et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer
Shun-ichi Watanabe et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2017)
Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients
Yueh-Hsiang Liao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Ginsenoside Rg3 Serves as an Adjuvant Chemotherapeutic Agent and VEGF Inhibitor in the Treatment of Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review
Tao Xu et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles
Antonio Rossi et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation
Yan Li et al.
ONCOTARGET (2016)
Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer
Maimon C. Rose et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2014)
Improving chemotherapy for patients with advanced non-small cell lung cancer
Christian von Plessen
CLINICAL RESPIRATORY JOURNAL (2011)
Karnofsky Performance Scale (KPS) or Physical Performance Test (PPT)? That is the question
Catherine Terret et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer
[Anonymous]
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2008)
分享论文
